LSL Pharma Group Inc. (TSXV:LSL)
Canada · Delayed Price · Currency is CAD 0.3700
-0.0050 (-1.33%)
Sep 10, 2025, 3:00 PM EDT
LSL Pharma Group Market Cap
LSL Pharma Group has a market cap or net worth of CAD 44.85 million as of September 11, 2025. Its market cap has decreased by -17.40% in one year.
Market Cap
44.85M
Enterprise Value
67.98M
Revenue
23.24M
Ranking
n/a
PE Ratio
11.98
Stock Price
0.37
Market Cap Chart
Since March 2, 2023, LSL Pharma Group's market cap has decreased from 61.67M to 44.85M, a decrease of -27.27%. That is a compound annual growth rate of -11.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 10, 2025 | 44.85M | -5.31% |
| Dec 31, 2024 | 47.37M | 18.48% |
| Dec 29, 2023 | 39.98M | -35.17% |
| Mar 2, 2023 | 61.67M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Curaleaf Holdings | 3.02B |
| Green Thumb Industries | 2.56B |
| Trulieve Cannabis | 1.92B |
| Sienna Senior Living | 1.67B |
| dentalcorp Holdings | 1.63B |
| Cronos Group | 1.35B |
| WELL Health Technologies | 1.17B |
| Extendicare | 1.08B |